Sing Tao News Corporation Limited (HKG:1105)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	211	195	339	361	449	872
Market Cap Growth	-42.60%	-42.60%	-6.10%	-19.61%	-48.48%	-37.46%
Enterprise Value	-307	-317	-143	-38	-149	328
Last Close Price	0.24	0.22	0.39	0.41	0.51	0.97
PS Ratio	0.27	0.25	0.41	0.44	0.54	1.06
PB Ratio	0.13	0.12	0.20	0.21	0.24	0.44
P/TBV Ratio	0.13	0.12	0.20	0.21	0.24	0.44
P/FCF Ratio	-	-	-	-	-	27.28
P/OCF Ratio	16.92	15.58	27.78	-	-	17.47
EV/Sales Ratio	-	-	-	-	-	0.40
EV/FCF Ratio	152.56	-	-	-	-	10.26
Debt / Equity Ratio	0.01	0.01	0.01	0.02	0.01	0.02
Debt / EBITDA Ratio	-	-	4.07	-	-	-
Debt / FCF Ratio	-	-	-	-	-	0.90
Asset Turnover	0.39	0.39	0.40	0.39	0.38	0.35
Inventory Turnover	24.94	24.94	18.66	16.21	20.90	20.64
Quick Ratio	4.29	4.29	4.52	3.88	3.80	4.27
Current Ratio	4.52	4.52	4.74	4.35	4.06	4.43
Return on Equity (ROE)	-5.06%	-5.06%	-2.86%	-7.78%	-7.32%	-4.06%
Return on Assets (ROA)	-3.37%	-3.37%	-2.25%	-4.79%	-4.42%	-3.53%
Return on Capital (ROIC)	-3.95%	-3.95%	-2.62%	-5.57%	-5.10%	-4.09%
Earnings Yield	-39.87%	-43.29%	-14.47%	-38.44%	-31.13%	-9.28%
FCF Yield	-0.95%	-1.03%	-1.21%	-27.62%	-21.99%	3.67%
Dividend Yield	-	-	-	-	-	2.06%
Buyback Yield / Dilution	-	-	-	-	-0.14%	-1.38%
Total Shareholder Return	-	-	-	-	-0.14%	0.69%

Updated Sep 11, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.